Related Experiment Video
Updated: Jul 17, 2026

High-Throughput Small Molecule Drug Screening For Age-Related Sleep Disorders Using Drosophila melanogaster
Published on: October 20, 2023
Effect of Betahistine on Daytime Sedation and Metabolic Parameters in Patients with Schizophrenia on
Sai Spoorthy Mamidipalli1, Lakshmi Sristi1, Barikar C Malathesh1
1AIIMS Bibinagar, Hyderabad, Telangana, India.
Background:
Second-generation antipsychotics (SGAs), widely used in the management of schizophrenia, have significant side effects like daytime sedation and metabolic derangement.
Novelty:
Betahistine (H1 agonist) has shown promising results for metabolic parameters and is less studied for the management of daytime sedation.
Objectives:
This study aims to evaluate the effect of Betahistine on daytime sedation and metabolic parameters in patients with schizophrenia on SGAs from baseline to 6 weeks.
Methods:
This open-label randomized control trial will recruit 76 participants (Purposive sampling) aged >18 years, any gender, with a diagnosis of Schizophrenia on SGAs at AIIMS Bibinagar. Participants will be assessed for daytime sedation using the Epworth Sleepiness Scale (ESS) and for metabolic derangement using blood investigations and body measurements. Participants will be randomly allocated (via opaque, sealed envelopes) to two groups. Group 1 will receive Betahistine and treatment as usual, and Group 2 will receive treatment as usual (existing antipsychotics). Participants in both groups will be followed up at 2, 4, and 6 weeks.
Expected Outcome:
Changes in daytime sedation will be assessed using ESS scores at each follow-up at 2, 4, and 6 weeks. Changes in metabolic parameters will be assessed using blood investigations and body measurements at baseline and 6 weeks.
Related Concept Videos
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Sedatives and Hypnotics: Overview
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Sedatives and Hypnotics Drugs: Benzodiazepines
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
Antipsychotic Drugs: Therapeutic Uses and Side Effects
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
Management of Insomnia
Sedatives and Hypnotics Drugs: Barbiturates